EMERYVILLE,CA, Ansa Biotechnologies announced it has closed a Series A financing round of $68M led by Northpond Ventures.
Ansa Biotechnologies announced it has closed an oversubscribed Series A financing round of $68 million led by Northpond Ventures.
Other investors include RA Capital, Blue Water Life Science Advisors, Altitude Life Science Ventures, Fiscus Ventures, PEAK6 Strategic Capital, Carbon Silicon Ventures, Codon Capital, and existing investors Mubadala Capital, Humboldt Fund, Fifty Years, and Horizons Ventures.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
